TNF and autoinflammatory syndrome: OTULIN‐related autoinflammatory syndrome patients respond poorly to standard anti‐inflammatory and immunosuppressive treatments (Damgaard et al, 2016; Zhou et al, 2016), but their inflammatory symptoms can be alleviated by neutralisation of TNF (Damgaard et al, 2016; Zhou et al, 2016).